Literature DB >> 22045822

Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.

Shlomo Birkenfeld1, Rachel Gingold Belfer, Miri Chared, Alex Vilkin, Micha Barchana, Irena Lifshitz, Dana Fruchter, Dina Aronski, Ran Balicer, Yaron Niv, Zohar Levi.   

Abstract

OBJECTIVE: To compare the uptake of faecal immunochemical occult blood test (FIT) with guaiac faecal occult blood test (gFOBT) in a screening programme, with specific attention to the demographic and socioeconomic factors that might affect test uptake.
SETTING: The Clalit Health Service screening programme, Israel.
METHODS: Average-risk individuals aged 50-75 years were randomized into a FIT arm or gFOBT arm using a programme based on the socioeconomic status (SES) of their primary care clinics. G-FOBT was performed with Hemoccult SENSA™ (3 evacuations) and FIT with the OC- MICRO(TM) (3 evacuations, refrigerating mandated). The GLIMMIX model was used.
RESULTS: There were 5,464 and 10,668 eligible participants in the FIT and gFOBT arms respectively. Compliance in taking the kits was better (but not statistically significantly better) with gFOBT (37.8% vs. 29.3%; odds ratio [OR] 1.43 [95% CI 0.73-2.80]; P = 0.227). Kit return was higher in the FIT arm (65.0% vs. 78.9%; OR 0.45 [95% CI 0.24-0.83], P = 0.021). Overall test uptake was affected by age, gender, being immigrant and SES (determined by whether or not the participant paid national insurance tax, and the SES of the primary care clinic). The overall uptake of gFOBT and FIT was comparable (OR 0.996 [95% CI 0.46-2.17], P = 0.99).
CONCLUSIONS: Overall compliance for test uptake was comparable between the two methods despite the more demanding procedure in the FIT arm. Sociodemographic parameters were the major determinants of compliance. An educational programme, with emphasis on the sociodemographic characteristics of the target population, should be instigated.

Entities:  

Mesh:

Year:  2011        PMID: 22045822     DOI: 10.1258/jms.2011.010147

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

Authors:  Jessica Chubak; Andy Bogart; Sharon Fuller; Sharon S Laing; Beverly B Green
Journal:  Prev Med       Date:  2013-09-09       Impact factor: 4.018

2.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

3.  Use of fecal immunochemical tests in the Iowa Research Network.

Authors:  Jeanette M Daly; Camden Bay; Barcey T Levy
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

4.  Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps.

Authors:  Haili Wang; Victor Tso; Clarence Wong; Dan Sadowski; Richard N Fedorak
Journal:  Clin Transl Gastroenterol       Date:  2014-03-20       Impact factor: 4.488

5.  Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.

Authors:  Benjamin Kearns; Sophie Whyte; Helen E Seaman; Julia Snowball; Stephen P Halloran; Piers Butler; Julietta Patnick; Claire Nickerson; Jim Chilcott
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.